Affiliation:
1. Department of Gastroenterology and Hepatology; Department of Medicine; University of Connecticut Health Science Center; Farmington CT USA
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Reference37 articles.
1. Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies;Chen;Gastroenterology,2013
2. Incidence and risk factors for hepatocellular carcinoma in patient with chronic hepatitis C after the eradication of HCV;Toyoda;Hepatology,2013
3. HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b;Pellicelli;BMC Gastroenterol,2012
4. The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C;Massoumy;Aliment Pharm Ther,2013
5. Virologic outcomes and adherence to treatment algorithms in a longitudinal study of patients with chronic hepatitis C treated with boceprevir (BOC) or telaprevir (TVR) in the United States (HCV-TARGET);Bisceglie;Hepatology,2013
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献